Mytrus Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Mytrus Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013319
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mytrus Inc (Mytrus) is an e-clinical technology company that specializes in patient-centered electronic informed consent and data collection tools. The company’s technology includes Enroll, an electronic informed consent and patient enrollment system for clinical trials. Mytrus develops new technologies for patients including ePRO and EDC tools, site training and e-learning applications, bio-sample consent tracking technology and patient home dashboards to track clinical study progress and data. The company also develops remote electronic consent and virtual data collection for clinical trials. It carries out virtual clinical trials in the US. The company is funded by BioClinica and inVentiv Health. Mytrus is headquartered in Davis, California, the US.

Mytrus Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mytrus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Mytrus Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Mytrus Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Mytrus Inc, Medical Devices Deals, 2011 to YTD 2017 8
Mytrus Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Mytrus Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Mytrus Completes Acquisition Of Rights To Clinical-Trials Management Patent From Boston University 10
Venture Financing 12
Mytrus Raises US$0.7 Million In Series B Financing 12
Licensing Agreements 13
Mytrus Enters Into Licensing Agreement With Boston University 13
Acquisition 14
Medidata Solutions to Acquire Mytrus 14
inVentiv Health Clinical Acquires Stake In Mytrus 15
Mytrus Inc – Key Competitors 16
Mytrus Inc – Key Employees 17
Mytrus Inc – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Mytrus Inc, Pharmaceuticals & Healthcare, Key Facts 2
Mytrus Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Mytrus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Mytrus Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Mytrus Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Mytrus Inc, Medical Devices Deals, 2011 to YTD 2017 8
Mytrus Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Mytrus Completes Acquisition Of Rights To Clinical-Trials Management Patent From Boston University 10
Mytrus Raises US$0.7 Million In Series B Financing 12
Mytrus Enters Into Licensing Agreement With Boston University 13
Medidata Solutions to Acquire Mytrus 14
inVentiv Health Clinical Acquires Stake In Mytrus 15
Mytrus Inc, Key Competitors 16
Mytrus Inc, Key Employees 17

★海外企業調査レポート[Mytrus Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Martin Mathew & Co. Ltd.:企業の戦略・SWOT・財務情報
    Martin Mathew & Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Martin Mathew & Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Companhia Energetica de Sao Paulo:企業の発電所・SWOT分析2018
    Companhia Energetica de Sao Paulo - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Shalimar Paints Ltd (SHALPAINTS):企業の財務・戦略的SWOT分析
    Shalimar Paints Ltd (SHALPAINTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Bangkok Bank Public Co Ltd:企業の戦略・SWOT・財務情報
    Bangkok Bank Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Bangkok Bank Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Occidental Chemical Corp:企業の戦略的SWOT分析
    Occidental Chemical Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Spicejet Limited
    Spicejet Limited - Strategy, SWOT and Corporate Finance Report Summary Spicejet Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • HiberGene Diagnostics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary HiberGene Diagnostics Ltd (HiberGene Diagnostics) is a medical equipment company that manufactures, develops and markets molecular diagnostic tests for human infectious diseases using the LAMP technology. The company’s products include HG C. Difficile, HG Meningococcus, HG Group B Streptococ …
  • Salt River Project:企業の戦略・SWOT・財務分析
    Salt River Project - Strategy, SWOT and Corporate Finance Report Summary Salt River Project - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Torishima Pump Mfg Co Ltd (6363):企業の財務・戦略的SWOT分析
    Torishima Pump Mfg Co Ltd (6363) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • NSK Ltd (6471):企業の財務・戦略的SWOT分析
    NSK Ltd (6471) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Korea Research Institute of Chemical Technology:製薬・医療:M&Aディール及び事業提携情報
    Summary Korea Research Institute of Chemical Technology (KRICT) is a chemical institute that develops chemical process technologies. The institute provides green technology, chemical materials, drug candidates, and chemistry based fusion technologies. Its green chemistry research includes petroleum …
  • Novartis Institutes for BioMedical Research Inc-製薬・医療分野:企業M&A・提携分析
    Summary Novartis Institutes for BioMedical Research Inc (NIBR), a subsidiary of Novartis AG is a medical research institute that offers treatment research and development programs. The institute offers clinical research services in areas of immuno-oncology, oncology, neuroscience, cardiovascular and …
  • Anthelio Healthcare Solutions Inc.-医療機器分野:企業M&A・提携分析
    Summary Anthelio Healthcare Solutions Inc. (Anthelio), formerly PHNS Inc., is a healthcare IT service company that offers information technology and business process services to hospitals, physician practice groups and other healthcare providers. The company’s suite of software solutions include int …
  • Elcelyx Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Elcelyx Therapeutics Inc (Elcelyx) is a developer of novel therapies for the treatment of type 2 diabetes, kidney disease and limb amputation. The company develops drugs that regulate the gut neuroendocrine system including the L-cell, which assists in the release of glucoregulatory hormones …
  • Canacol Energy Ltd (CNE):石油・ガス:M&Aディール及び事業提携情報
    Summary Canacol Energy Ltd (Canacol Energy) is an oil and gas company that explores and produces conventional and unconventional oil fields. The company operates oil and gas reserves in Caguan-Putumayo basin, Lower Magdalena basin, Llanos basin, Magdalena basin in Colombia; and Oriente basin in Ecua …
  • Vedanta Ltd:企業の戦略・SWOT・財務情報
    Vedanta Ltd - Strategy, SWOT and Corporate Finance Report Summary Vedanta Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • PetroChina Co Ltd (857):企業の財務・戦略的SWOT分析
    PetroChina Co Ltd (857) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • GNI Group Ltd (2160):製薬・医療:M&Aディール及び事業提携情報
    Summary GNI Group Ltd (GNI) is a healthcare service provider that researches, develops, manufactures and markets pharmaceutical drugs. The company’s business operations consist of drug discovery activities such as drug discovery research, drug discovery infrastructure, fundamental drug discovery, an …
  • Omega Pharma NV:企業のM&A・事業提携・投資動向
    Omega Pharma NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Omega Pharma NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Kore Potash Plc (ELM):企業の財務・戦略的SWOT分析
    Summary Kore Potash Plc (Kore Potash), formerly Elemental Minerals Ltd, is a mining company that offers exploration and development of mineral resources. The company offers development of potash project in the Republic of Congo and operates an exploration project in Australia. It also owns and opera …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆